Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Ursodeoxycholic Acid in Refractory PBC
NCT03345589Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in primary biliary cholangitis (PBC), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT03345589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345589.